TCTR20230703002CompletedNot Applicable
Assessment of Direct Oral Anticoagulant Use and Clinical Outcomes among Patients with Kidney Impairment at Faculty of Medicine Siriraj Hospital Mahidol University
Faculty of Medicine Siriraj Hospital Mahidol University0 sites320 target enrollmentStarted: July 3, 2023Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Enrollment
- 320
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 18 Years to N/A (No limit) (—)
- Sex
- All
Inclusion Criteria
- •Adult patients with eGFR <60 mL/min/1.73 m2 assessed by CKD-EPI equation
Exclusion Criteria
- •Patients who lost follow-up during the study period, patients who do not have a baseline serum creatinine within 3 months, and patients unable to have serum creatinine monitored for 6 months after the previous visit.
Investigators
Similar Trials
Recruiting
Not Applicable
Comparison between Direct Oral Anticoagulation (DOAC) Interruption and DOAC Continuation in Patients Undergoing Elective Invasive Coronary Angiography or Percutaneous Coronary Interventio10011082Chronic Coronary SyndromeCoronary Artery DiseaseNL-OMON51007Zuyderland Medisch Centrum1,270
Recruiting
Not Applicable
The safety and efficacy of direct oral anticoagulants in patients with atrial fibrillation (AF)atrial fibrillationJPRN-UMIN000030673Tokyo Medical and Dental University1,000
Recruiting
Unknown
Comparative efficacy and safety of pill-in-the-pocket anticoagulation strategyDiseases of the circulatory systemKCT0008995Seoul National University Hospital400
Recruiting
Not Applicable
Effects of treatment with oral anticoagulant associated with antibiotic therapy in Covid-19Covid-19B04.820.578.500.540.150RBR-7nzwkpgniversidade do Sul de Santa Catarina
Completed
Not Applicable
Bleeding events of direct oral anti-coagulant for treatment of venous thromboembolism in advanced cancer patients.Venous thromboembolismJPRN-UMIN000020275Shizuoka Cancer Center147